{"url_path":"/sec/supn/8-k/2026-07-22/item-9-01","section_key":"item-9-01","section_title":"Item 9.01 Financial Statements and Exhibits.","topic":"sec","document":{"doc_type":"8-K","doc_date":"2026-07-22","source_url":"https://www.sec.gov/Archives/edgar/data/1356576/0001356576-26-000031-index.html","accession_number":"0001356576-26-000031","cik":"0001356576","ticker":"SUPN","issuer_name":"SUPERNUS PHARMACEUTICALS, INC.","edgar_url":"https://www.sec.gov/Archives/edgar/data/1356576/0001356576-26-000031-index.html","primary_entity_key":"0001356576","primary_entity_name":"SUPERNUS PHARMACEUTICALS, INC."},"word_count":92,"has_tables":true,"body_markdown":"Item 9.01 Financial Statements and Exhibits.\n\n(d) Exhibits\n\nExhibitDescription\n\n99.1\n[Press Release dated July 22, 2026](ex-99107x22xearningscallan.htm) filed as an Exhibit pursuant to Item 2.02 hereof.\n\n104The cover page from this Current Report on Form 8-K, formatted in Inline XBRL.\n\n2\n\nSIGNATURES\n\n \n\nPursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. \n\n SUPERNUS PHARMACEUTICALS, INC.\n\n  \n\nDATED: July 22, 2026By:/s/ Timothy C. Dec\n\n  Timothy C. Dec\nSenior Vice President and Chief Financial Officer\n\n3"}